OBJECTIVE: Sepsis criteria that require the use of physiological parameters do not account for pregnancy changes. We sought to compare trends in the prevalence and healthcare cost of deliveryrelated sepsis using two definitions of sepsis. STUDY DESIGN: We conducted a serial, cross-sectional analysis using data from the 2002-15 National Inpatient Sample, the largest allpayer inpatient database in the United States. We used ICD-9-CM diagnosis and procedure codes to identify the study sample of delivery-related hospitalizations, and to capture diagnoses of sepsis using 1) the Sepsis-2 definition, and 2) the World Health Organization (WHO) definition of maternal sepsis (suspected/ confirmed infection with evidence of end-organ damage). We assessed differences in the frequency, prevalence, and temporal trends of sepsis, patient and hospital characteristics, and hospital utilization measures (length of stay, direct hospital medical costs) and in-hospital mortality associated with sepsis. RESULTS: Of the more than 55 million delivery-associated hospitalizations, 13,129 and 45,550 were affected by sepsis based on the Sepsis-2 and WHO definitions, respectively. The rate of sepsis using old criteria was 2.4 vs. 8.3 per 10,000 using new criteria. The rate of sepsis increased during the study period under both definitions with annual percent increases of 6.7% (Sepsis-2) and 7.5% (WHO). In-hospital mortality rate among those with sepsis based on the WHO definition (3.1%) was lower than Sepsis-2 (9.4%). Hospital utilization was statistically significantly higher for Sepsis-2 (mean length of stay (LOS): 15 days; mean cost: $53,700) than for the WHO definition (mean LOS: 9 days; mean cost: $27,100; p<.0001). However, due to the increased number of cases maternal sepsis under the WHO definition, the estimated average annual cost of direct medical care for women with sepsis during delivery was higher for the WHO definition ($84.2 vs. $50.0 million). Regardless of the definition used, all clinical outcomes were significantly increased compared to delivery-associated hospitalizations unaffected by sepsis.
CONCLUSION:
The newer WHO definition classifies significantly more cases as delivery-associated sepsis, and despite capturing less severe cases, may allow an opportunity for more aggressive treatment in an effort to improve outcomes. OBJECTIVE: Many patients will require intravenous (IV) access during the course of pregnancy and peripherally inserted central catheters (PICCs) are commonly used to obtain long-term IV access. Pregnancy is associated with an altered immune response and is also a prothrombotic state; therefore, a theoretical safety concern surrounds the antenatal use of PICCs. The objective of this study was to assess the rate of complications associated with use of PICCs in pregnancy STUDY DESIGN: In order to assess the rate of complications associated with antenatal PICC use, a systematic review was performed by searching published literature for records discussing PICC use in pregnant or postpartum women. We performed a MEDLINE esearch through Pubmed, EMBASE, Scopus, the Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHLPlus, and Clinicaltrials.gov. We included studies with primary data regarding rates of maternal complications from PICC use (infectious, thromboembolic, mechanical failure, superficial thrombophlebitis). Meta-analysis was performed using STATA 12 with the METAN and METAPROP software routines. Pooled estimates with 95%CI were calculated using a random effects model after Freeman-Tukey Double Arcsite Transformation. RESULTS: After removal of duplicates, the primary search yielded 318 articles, with 5 being included for final analysis. The pooled rate of combined infectious and thromboembolic complications was 25% (95%CI 6-50%). Secondary outcomes showed that the pooled rate Poster Session IV 
